Ovarian Cancer – Managing the Side Effects of Treatment
by Wendy Topeka BSN, RN, OCN
When a woman hears the words “you have ovarian cancer,” it is from that very moment that a partnership begins between the woman, her family, and the doctors and nurses caring for her. This partnership is a key element in the treatment and management of ovarian cancer. It is this relationship that will help her tackle any side effect or challenge she may face related to this diagnosis.
Communicating with Your Doctor after an Ovarian Cancer Diagnosis
by Stephanie V. Blank, MD
Of course, it’s not only women with ovarian cancer who need to consider the importance of communication with their doctor – anyone who has ever had cancer, or anyone who has ever been to the doctor, can improve their care by taking time to consider what they need and want to learn from interaction with their physician. Here, we’ll address issues specific to ovarian cancer, but many of these concepts are universal.
Modified Chemotherapy Regimen Effective in Advanced Ovarian Cancer
Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination.
by Thomas J. Herzog, MD, and Robert L. Coleman, MD
Women who are suspected of having ovarian cancer and women who have been diagnosed with ovarian cancer often receive a blood test to measure their CA-125 level. CA-125 is a substance found in the blood called a glycoprotein (a sugar-associated protein). It is commonly referred to as a biomarker or tumor marker because it provides information about the biological state of a disease (ovarian cancer) and is obtained by a blood sample from which a level can be measured. But it is more accurately considered a tumor associated protein because elevated CA-125 levels do not always indicate ovarian cancer, and levels can be misleading.
New Surgical Technique Shows Promising Results for Women with Cervical Cancer
A new surgical technique could allow surgeons to perform a radical hysterectomy in women with early-stage cervical cancer – with fewer complications, reduced morbidity, and a lower risk of local tumor recurrence than current surgical methods, according to an article published in The Lancet Oncology.
The National Cervical Cancer Coalition/HPV Cancer Coalition
by Sarina Araujo
(NCCC) is a grassroots nonprofit organization helping women, family members, and friends battle the personal issues related to cervical cancer and HPV (human papillomavirus) disease. The NCCC has expanded its core mission to include helping both women and men who battle issues related to all HPV cancers; therefore, the NCCC is also called the HPV Cancer Coalition.
NCCN Releases Updated Guidelines for Ovarian Cancer
At the National Comprehensive Cancer Network Annual Conference in March, Robert J. Morgan, MD, of City of Hope Comprehensive Cancer Center and chair of the NCCN Guidelines Panel for Ovarian Cancer, discussed the future of ovarian cancer and notable changes to the recently updated NCCN Clinical Practice Guidelines in Oncology™ for Ovarian Cancer. New to the Guidelines is a section on the management of allergic reactions in women receiving chemotherapy for ovarian cancer.
General Information About Cervical Cancer
Cervical cancer is a disease in which malignant (cancer) cells form in the tissues of the cervix. Cervical cancer usually develops slowly over time. Before cancer appears in the cervix, the cells of the cervix go through changes known as dysplasia, in which cells that are not normal begin to appear in the cervical tissue. Later, cancer cells start to grow and spread more deeply into the cervix and to surrounding areas.